Dare Bioscience Investor Presentation Deck
Women's Health - An Efficient Investment Thesis
Approximately 1% of healthcare research is
invested in female-specific conditions
beyond oncology. ¹
Women's Health conditions outside of
oncology comprise less than 2% of the
current healthcare pipeline.²
1 - McKinsey & Company, February 14, 2022, Unlocking Opportunities in Women's Healthcare
2 - GlobalData Drugs Database and McKinsey & Company
3- IQVIA Monthly Global MIDAS $ Const-Exchng (MNF) 2013-2022
Blockbuster defined as $500 million dollar sales in a year
Women's Health including conditions disproportionately affecting women
We believe investment in women's
health will be efficient and
disproportionately impactful:
Q-Women's Health products
make up 27% of total blockbuster
products while contributing to
35% of total blockbuster sales.3
Women control 80% of U.S.
healthcare purchasing decisions.¹
-
4View entire presentation